Clinical Trial Update: To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating repeated intranasal ketamine for post-traumatic stress disorder has been withdrawn, removing Phase 2/Phase 3 efforts from active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Adriana Feder | Conditions: PTSD | Phase 2, Phase 3 | Status: WITHDRAWN